Deployment of convalescent plasma for the prevention and treatment of COVID-19Evan M. Bloch, Aaron A.R. Tobian, Lewis Pollack et al.|Journal of Clinical Investigation|2020Cited by 863
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor populationSabra L. Klein, Aaron A.R. Tobian, Andrew Pekosz et al.|Journal of Clinical Investigation|2020Cited by 480
SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individualsHassen Kared, Thomas C. Quinn, Andrew D. Redd et al.|Journal of Clinical Investigation|2021Cited by 276
Early Outpatient Treatment for Covid-19 with Convalescent PlasmaDavid Sullivan, David Shade, Kelly A. Gebo et al.|New England Journal of Medicine|2022Cited by 269
Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing TitersEshan U. Patel, Oliver Laeyendecker, Evan M. Bloch et al.|Journal of Clinical Microbiology|2020Cited by 198